Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistCanada Med Stop sold unapproved and misbranded compounded semaglutide products to U.S. consumers through its website, falsely claiming the products were "FDA-Approved," "Generic," and contained "the same active ingredient in branded weight loss medications." The company violated federal law by marketing compounded drugs with false or misleading claims that implied equivalence to FDA-approved products, when compounded drugs are not FDA-approved. These misbranded products were unlawfully introduced into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act.